Board of Directors
Leading New Gene-based Therapies
Enochian Biosciences Announces Appointment of Dr. Mark Dybul as Executive Vice-Chair
January 7, 2019
Enochian Biosciences Announces Uplisting to NASDAQ Under Symbol "ENOB"
December 5, 2018
Enochian Biosciences Attending 60th ASH on Nov 30—Dec 4 in San Diego, CA
November 27, 2018
Enochian Biosciences to Present at Biotech Showcase 2019
November 23, 2018
Enochian Biosciences Attending Cell & Gene Meeting on the Mesa on October 3-5, 2018 in La Jolla, California.
September 4, 2018
Enochian Biosciences Announces Appointment of Dr. David Hardy to Scientific Advisory Board
July 20, 2018
Dandrit Biotech announces filing of listing application to the Nasdaq capital market
February 23, 2018
Dandrit Biotech announces completion of the acquisition of Enochian
February 20, 2018
Dandrit Biotech announces acquisition of Enochian New York, NY
January 17, 2018
DanDrit Biotech USA Inc. Announces new Therapeutic Research Strategy
June 12, 2017
DanDrit Biotech A/S to Present at the Investor Day in Copenhagen Tuesday, September 22, 2015.
September 22, 2015
DanDrit Biotech to Present at, Cancer Vaccines Advancing Immuno-oncology
September 16, 2015
DanDrit Biotech Analyst Coverage Initiated: Report Issued by Nordic Bio Investor.
July 17, 2015
DanDrit Biotech to Present at the 5th Annual Outsourcing in Clinical Trials Europe 2015
May 19, 2015